SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 16, 2004
MACROPORE BIOSURGERY, INC.
(Exact name of registrant as specified in Charter)
Delaware |
| 000-32501 |
| 33-0827593 |
(State or Other Jurisdiction |
| (Commission File |
| (IRS Employer |
|
|
|
|
|
6740 Top Gun Street, San Diego, California |
| 92121 | ||
(Address of Principal Executive Offices) |
| (Zip Code) | ||
|
|
| ||
Registrant’s telephone number, including area code: (858) 458-0900 |
Item 7. Financial Statements and Exhibits
(c) Exhibits
Exhibit 99.1 Press release issued by MacroPore Biosurgery, Inc. on August 16, 2004, reported financial results for the quarter ended June 30, 2004.
Item 12. Results of Operation and Financial Condition
Press release issued by MacroPore Biosurgery, Inc. on August 16, 2004, reporting financial results for the quarter ended June 30, 2004. A copy of the press release is attached hereto as Exhibit 99.1.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| MACROPORE BIOSURGERY, INC. | |||||
|
|
|
|
|
| ||
|
|
|
|
|
| ||
Dated: | August 16, 2004 |
|
| By: | /s/ Christopher J. Calhoun |
| |
|
|
|
|
| |||
|
|
| Christopher J. Calhoun |
| |||
|
|
| President and Chief Executive Officer | ||||
3
EXHIBIT INDEX
Exhibit |
| Description of Document |
|
|
|
99.1 |
| Press release issued by MacroPore Biosurgery, Inc. on August 16, 2004, reporting financial results for the quarter ended June 30, 2004. |
4